0001628280-24-032153.txt : 20240717 0001628280-24-032153.hdr.sgml : 20240717 20240717213147 ACCESSION NUMBER: 0001628280-24-032153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240715 FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harris Taylor C. CENTRAL INDEX KEY: 0001560168 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50644 FILM NUMBER: 241123570 MAIL ADDRESS: STREET 1: 6035 STONERIDGE DRIVE CITY: PLEASANTON STATE: CA ZIP: 94588 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUTERA INC CENTRAL INDEX KEY: 0001162461 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770492262 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 94005 MAIL ADDRESS: STREET 1: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: ALTUS MEDICAL INC DATE OF NAME CHANGE: 20011119 4 1 wk-form4_1721266300.xml FORM 4 X0508 4 2024-07-15 0 0001162461 CUTERA INC CUTR 0001560168 Harris Taylor C. C/O CUTERA, INC. 3240 BAYSHORE BLVD. BRISBANE CA 94005 1 1 0 0 Chief Executive Officer 0 Stock Option (Right to Buy) 16.84 2024-07-15 4 D 0 25327 0 D 2030-05-19 COMMON STOCK 25327 0 D Stock Option (Right to Buy) 1.54 2024-07-15 4 A 0 25327 0 A 2030-05-19 COMMON STOCK 25327 25327 D Stock Option (Right to Buy) 11.02 2024-07-15 4 D 0 735295 0 D 2030-08-18 COMMON STOCK 735295 0 D Stock Option (Right to Buy) 1.54 2024-07-15 4 A 0 735295 0 A 2030-08-18 COMMON STOCK 735295 735295 D Stock Option (Right to Buy) 2.23 2024-07-15 4 D 0 200000 0 D 2031-05-13 COMMON STOCK 200000 0 D Stock Option (Right to Buy) 1.54 2024-07-15 4 A 0 200000 0 A 2031-05-13 COMMON STOCK 200000 200000 D One-third of the shares subject to the option vested on May 19, 2024 and one-third of the shares subject to the option vest each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. On July 15, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $1.54 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. One-fourth of the shares subject to the option will be eligible to vest upon the date the 30 calendar-day trailing average closing price of the Issuer's common stock first meets each of the following levels within four years of the grant date: $20.00, $25.00, $30.00, and $35.00. Once a level is attained, one-fourth of the options subject to such tranche will vest on the later of (i) the date such level is attained or (ii) August 7, 2024. The remaining options in such tranche will vest over the next 12 quarters, subject to the Reporting Person continuing as a service provider through each such date. The shares subject to the option shall vest 1/48 per month from April 25, 2024, subject to the Reporting Person continuing to be a service provider through each such date. /s/ Stuart Drummond, by power of attorney 2024-07-17